Premium Information is available for this item - Upgrade for $1 a day
6505-01-033-1299
Dantrolene Sodium Capsules
6505010331299 010331299 DANTRIUM NDC035-0033-01
INC: 32518 Dantrolene Sodium Capsules
November 2023
7
Marketplace 6505-01-033-1299
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-033-1299 5+ Documents (More...)
6505-01-033-1299 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-033-1299
Sodium Capsules 6505010331299 Sodium Capsules 6505010331299 Dantrolene Sodium https//www.nsnlookup.com
6505-01-153-3552 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-033-1299 Dantrolene Sodium
Capsules 6505010331299 Dantrolene Sodium Capsules 65050115335526505-01-153-3552 https//www.nsnlookup.com
Dantrolene Sodium Capsules 6505010331299 1299 6505-01-153-3552 https Capsules 6505010331299 https
Dantrolene Sodium Capsules 6505144861562 Capsules 6505011533553 https//www.nsnlookup.com https/ 6505010331299
https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-033-1299 Dantrolene Sodium Capsules 6505010331299
Dantrolene Sodium Capsules Dantrolene Sodium Capsules 6505010331299 Dantrolene Sodium Capsules 6505145720143
Dantrolene Sodium Capsules 6505010331299 day Upgrade your Account Upgrade 6505-01-033-1299Dantrolene
Sodium Capsules6505010331299 010331299 DANTRIUM Sodium Capsules Dantrolene Sodium Capsules 6505010331299
Restrictions 6505-01-033-1299
6505-01-033-1299 is a Dantrolene Sodium Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
End Users 6505-01-033-1299
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-033-1299
- Part Number
- Manufacturer
- Status
- NDC035-0033-01
- Manufacturer
- 04547 - Procter & Gamble Pharmaceuticals, (Active)
- Primary Buy
- Primary Buy
- DANTRIUM
- 04547 - Procter & Gamble Pharmaceuticals, (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-033-1299
- Characteristic
- Specifications
- Capsule Type [AKJC]
- Specifications
- Any Acceptable
- Capsule Content Form [CQLS]
- Any Acceptable
- Active Medicament Medicinal Strength [AKJA]
- 100.000 Milligrams Dantrolene Sodium Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Capsule Primary Container Content Quantity [CYLZ]
- 100.000
Similar Supply Items to 6505-01-033-1299
Freight Information 6505-01-033-1299
6505-01-033-1299 has freight characteristics.. 6505-01-033-1299 has a variance between NMFC and UFC when transported by rail and the description should be consulted.